Overview
Description
InhaleRx Limited, a biotechnology company, develops and sells registrable inhaled drug-device combinations in Australia. It is developing IRX-211 that has completed Phase 1 clinical trial for the treatment of Breakthrough Cancer Pain (BTcP); and IRX-616a that is in preclinical trial for panic disorder (PD). The company was formerly known as Lifespot Health Ltd and changed its name to InhaleRx Limited in October 2021. InhaleRx Limited was incorporated in 2016 and is headquartered in Melbourne, Australia.
About
CEO
Employees
0
Address
505 Little Collins Street
Level 9
Melbourne, 3000, VIC
Australia
Level 9
Melbourne, 3000, VIC
Australia
Phone
61 3 8678 4091
Website
Instrument type
Common stock
Sector
Industry
Country
Australia
MIC code
CXAC